Matrix Capital Management Company, LP, 10% Owner at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 4,760,000 shares at $22.66 ($107.9M) on 2023-06-20, disclosed to the SEC on 2023-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| AURA | BUY | 2022-12-07 | $15.0M | — | Filing → |
| ADPT | SELL | 2021-03-10 | $60.2M | — | Filing → |
| ADPT | SELL | 2020-07-22 | $80.0M | — | Filing → |